Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB957-100 - Provider product page
- Provider
- R&D Systems
- Product name
- Human/Primate GDF-15 Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified from hybridoma culture supernatant. Detects human GDF-15 in ELISAs and Western blots. In ELISAs, no cross-reactivity with recombinant human GDF-11, recombinant mouse (rm) GDF-5, rmGDF-6, rmGDF-7, or rmGDF-8 is observed.
- Reactivity
- Human, Simian
- Host
- Mouse
- Conjugate
- Unconjugated
- Antigen sequence
Q99988
- Isotype
- IgG
- Antibody clone number
- 147627
- Vial size
- 100 ug
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Submitted references TGF-β contamination of purified recombinant GDF15.
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia.
Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancer.
Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells.
Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy.
Olsen OE, Skjærvik A, Størdal BF, Sundan A, Holien T
PloS one 2017;12(11):e0187349
PloS one 2017;12(11):e0187349
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia.
Maetzler W, Deleersnijder W, Hanssens V, Bernard A, Brockmann K, Marquetand J, Wurster I, Rattay TW, Roncoroni L, Schaeffer E, Lerche S, Apel A, Deuschle C, Berg D
PloS one 2016;11(3):e0149349
PloS one 2016;11(3):e0149349
Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancer.
Li J, Veltri RW, Yuan Z, Christudass CS, Mandecki W
PloS one 2015;10(4):e0122249
PloS one 2015;10(4):e0122249
Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells.
Tanno T, Lim Y, Wang Q, Chesi M, Bergsagel PL, Matthews G, Johnstone RW, Ghosh N, Borrello I, Huff CA, Matsui W
Blood 2014 Jan 30;123(5):725-33
Blood 2014 Jan 30;123(5):725-33
Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy.
Foley PW, Stegemann B, Ng K, Ramachandran S, Proudler A, Frenneaux MP, Ng LL, Leyva F
European heart journal 2009 Nov;30(22):2749-57
European heart journal 2009 Nov;30(22):2749-57
No comments: Submit comment
No validations: Submit validation data